Both in Biotechnology
Cognition Therapeutics vs Champions Oncology
Over the past year CGTX returned −59.2% and CSBR returned −29.1%; their daily moves had a correlation of 0.07.
CGTX −59.2% CSBR −29.1%Growth of $1, one year, split-adjusted
| Metric | CGTX | CSBR |
|---|---|---|
| Price | $0.6405 | $4.79 |
| Market cap | $60.9M | $66.7M |
| Today | −6.26% | −0.83% |
| 1 month | −31.6% | −1.8% |
| 6 months | −44.8% | −20.0% |
| Year to date | −52.6% | −30.7% |
| 1 year | −59.2% | — |
| Revenue growth (YoY) | — | +8.8% |
| Gross margin | — | 50.5% |
| Net margin | — | −2.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 1.1× |
| Net cash | $34.0M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 48.8% | 34.9% |
| Short % of float | 8.3% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).